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Correction to: Alz Res Ther 12, 56 (2020)
https://doi.org/10.1186/s13195-020-00601-w
Following publication of the original article [1], the
authors reported a production error in the article title.
The last word "diseases" was omitted by copy editor.
The original article [1] has been updated.
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